From the Desk of Steve Strazza

The largest insider buy on today’s list comes in a Form 4 filing by Thurman John Rodgers, director of Enphase Energy Inc $ENPH.

Rodgers reported a purchase of $4 million in ENPH.

From the Desk of Steve Strazza

The most significant insider purchase on today’s list comes from Wayne P. Rothbaum, director of Iovance Biotherapeutics $IOVA.

Rothbaum declared a $26.5 million IOVA purchase in a Form 4 filing.

From the Desk of Steve Strazza

The largest insider buy on today’s list comes in a Form 4 filing by Biotechnology Value Fund LP.

The hedge fund revealed a purchase of roughly $14.8 million in Olema Pharmaceuticals $OLMA.

From the Desk of Steve Strazza

The largest insider buy on today’s list comes in a Form 4 filing by Ares Management LLC.

The hedge fund reported a purchase of roughly $2.1 million in Frontier Communications Parent $FYBR.

From the Desk of Steve Strazza

The largest insider buy on today’s list comes in a Form 4 filing by Carl Icahn.

Icahn revealed a purchase of $7.8 million in Southwest Gas Holdings $SWX.

From the Desk of Steve Strazza

The largest insider transaction on today’s list comes in a Form 4 filed by Coliseum Capital Management LLC.

The hedge fund reported a purchase of ModivCare Inc $MODV shares with a total value of $6.4 million.

From the Desk of Steve Strazza

The largest insider transaction on today’s list comes in a Form 4 filed by Low Check Kian, director of Broadcom Inc $AVGO.

Kian reported a purchase of 11,000 AVGO shares, equivalent to roughly $9.5 million.

From the Desk of Steve Strazza

The largest insider transaction on today’s list comes in a Form 4 filed by Broadwood Capital.

The hedge fund revealed a purchase of $7.8 million in STAAR Surgical Company $STAA, increasing its ownership stake to 18%.

From the Desk of Steve Strazza

The largest insider transaction on today’s list comes in a Form 4 filed by Kevin Stein, director of Axalta Coating Systems Ltd $AXTA.

Stein reported a purchase of 36,600 AXTA shares, equivalent to $1 million.

From the Desk of Steve Strazza

The largest insider transaction on today’s list comes in a Form 4 filed by Sylebra Capital Ltd, which revealed an additional purchase of $5.2 million in Impinj Inc $PI.

Patrick J. Heron, director of Mirum Pharmaceuticals $MIRM, revealed a purchase of 147,991 shares, equivalent to $3,884,763.

From the Desk of Steve Strazza

The largest insider transaction on today’s list comes in a Form 4 filed by Sylebra Capital Ltd, which revealed a purchase of $8 million in Impinj Inc $PI.

The hedge fund now owns 3,869,196 shares, representing an ownership stake of roughly 14%.

From the Desk of Steve Strazza

The largest insider transaction on today’s list comes in a Form 4 filed by Viking Global Investors.

The hedge fund reported a purchase of roughly $9.8 million in Inhibrx Inc $INBX, increasing its ownership stake to 16.40%.